Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000929638-24-001470
Filing Date
2024-04-15
Accepted
2024-04-15 16:32:50
Documents
1
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 POS 30830
  Complete submission text file 0000929638-24-001470.txt   32117
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-210285 | Film No.: 24845074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)